Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor

Journal of Experimental Medicine

Volumn 167, Issue 5, 1988, Pages 1737-1742

  Yamaguchi, Yuji ^a   Hayashi, Yoshihiko ^b   Sugama, Yasuo ^c   Miura, Yasusada ^a   Kasahara, Tadashi ^a   Kitamura, Satoshi ^c   Torisu, Masamichi ^b   Mita, Seiji ^d   Tominaga, Akira ^d   Takatsu, Kiyoshi ^d   Suda, Toshio ^a,d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Department of Medicine ^*  (Japan)

^d KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE GROWTH FACTOR; CYTOKINE; INTERLEUKIN 5;

ALLERGIC DISEASE; ANIMAL; ANIMAL CELL; CELL CULTURE; CHEMOTAXIS; EOSINOPHIL; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; T LYMPHOCYTE;

ANIMAL; CELL SURVIVAL; CELLS, CULTURED; CHEMOTACTIC FACTORS; EOSINOPHILS; FEMALE; INTERLEUKIN-5; INTERLEUKINS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T;

EID: 0023893708     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.167.5.1737     Document Type: Article

References (19)

1. Takatsu, K., K. Tanaka, A. Tomizuka, Y. Kumahara, and T. Hamaoka. 1980. Antigen-induced T cell-replacing factor (TRF). III. Establishment of a T cell hybrid clone continuously producing TRF and functional analysis of released TRF. J. Immunol. 125:2646.
2. Takatsu, K., N. Harada, Y. Hara, Y. Takahama, G. Yamada, K. Dobashi, and T. Hamaoka. 1985. Purification and physicochemical characterization of murine T cell replacing factor (TRF). J. Immunol. 134:382.
3. Harada, N., Y. Kikuchi, A. Tominaga, S. Takaki, and K. Takatsu. 1985. BCGF II activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hibridoma (B151K12). J. Immunol. 134:3944.
4. Yokota, T., R. L. Coffman, H. Hagiwara, D. M. Rennick, Y. Takebe, K. Yokota, L. Gemmell, B. Shrader, G. Yang, P. Meyerson, J. Luh, P. Hoy, J. Péne, F. Briére, H. Spits, J. Banchereau, J. de Vries, F. D. Lee, N. Arai, and K.-I. Arai. 1987. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgAenhancing factor and eosinophil colony stimulating factor activities:Relationship to interleukin-5. Proc. Natl. Acad. Sci. USA. 84:7388.
5. Loughnan, M. S., K. Takatsu, N. Harada, and G. J. V. Nossal. 1987. T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells. Proc. Natl. Acad. Sci. USA. 84:5399.
6. Sanderson, C. J., A. O’Garra, D. J. Warren, and G. G. B. Klaus. 1986. Eosinophil differentiation factor also has B-cell growth factor activity:Proposed name interleukin 4. Proc. Natl. Acad. Sci. USA. 83:437.
7. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin (IL-5) support the terminal differentiation proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43.
8. Kinashi, T., N. Harada, E. Severinson, T. Tanabe, P. Sideras, M. Konishi, C. Azuma, A. Tominaga, S. Bergstedt-Lindgvist, M. Takahashi, F. Matsuda, Y. Yaoita, K. Takatsu, and T. Honjo. 1986. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor 11. Nature (Lond.). 324:70.
9. Harada, N., T. Takahashi, M. Matsumoto, T. Kinashi, J. Ohara, Y. Kikuchi, N. Koyama, E. Severinson, Y. Yaoita, T. Honjo, N. Yamaguchi, A. Tominaga, and K. Takatsu. 1987. Production of a monoclonal antibody useful in the molecular characterization of murin T-cell-replacing factor/B-cell growth factor 11. Proc. Natl. Acad. Sci. USA. 84:4581.
10. Nagata, S., M. Tsutiya, S. Asano, Y. Kajiro, T. Yamazaki, O. Yamamoto, Y. Hirata, N. Kubota, M. Oheda, H. Nomura, and M. Ono. 1986. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature (Loud.). 319:415.
11. DeLamarter, J. F., J. J. Mermod, C. M. Liang, J. F. Eliason, and D. R. Thatcher. 1985. Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific antiserum. EMBO (Eur. Mol. Biol. Organ.)J. 4:2575.
12. Yokota, T., F. Lee, D. Rennick, C. Hall, N. Arai. T. Mossman, G. Nabel, H. Cantor, and K. Arai. 1984. Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells. Proc. Natl. Acad. Sci. USA. 81:1070.
13. Iscove, N. N., F. Sieber, and K. H. Winterhalter. 1974. Erythroid colony formation in cultures of mouse and human bone marrow. Analysis of the requirement for erythropoitin by gel filtration and affinitychromatography on agarose-concanavalin A. J. Cell. Physiol. 83:309.
14. Ward, P. A., C. G. Cochrane, and H. J. Muller-Eberhard. 1965. The role of serum complement in chemotaxis of leukocytes in vitro. J. Exp. Med. 122:327.
15. Zigmond, S. H., and J. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis:new methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137:387.
16. Litt, M., 1963. Studies in experimental eosinophilia. V. Eosinophils in lymph nudes of guinea pigs following primary antigenic stimulation. Am. I. Pathol. 42:529.
17. Lopez, A. F., L. B. To, Yu-C, Yang J. R. Gamble, M. F. Shannon, G. F. Burns, P. G. Dyson, C. A. Juttner, S. Clark, and M. A. Vadas. 1987. Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3. Proc. Natl. Acad. Sci. USA. 84:2761.
18. Colley, D. G. 1973. Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP):a lymphokine induced by specific antigen or phytohemagglutinin. J. Immunol. 110:1419.
19. Anwar, A. R. E., and A. B. Kay. 1981. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature (Lond.). 269:522.